Cardiovascular risk, metabolic disturbances, and the choice of antihypertensive therapy

QR Code

Cardiovascular risk, metabolic disturbances, and the choice of antihypertensive therapy

Aim. To study antihypertensive and metabolic effects of combined antihypertensive therapy with fixed doses of ACE inhibitor and thiazide-like diuretic (Noliprel®), in comparison with ACE inhibitor monotherapy (ramipril). Material and methods. The study included 44 men, aged 30-65 years, with Stage I...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. N. Mamedov, M. V. Stroeva, R. T. Didigova, E. A. Poddubskaya, M. N. Kovrigina
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2011-08-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	cardiovascular risk metabolic disturbances ramipril combined antihypertensive therapy noliprel
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1892
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EFFECT OF ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND ERECTILE FUNCTION IN HYPERTENSIVE MEN WITH HIGH CARDIOVASCULAR RISK: FOCUS ON THE COMBINATION OF LISINOPRIL AND AMLODIPINE
by: M. N. Mamedov, et al.
Published: (2016-01-01)

Metabolic effects of antihypertensive medications: prognostic role in the development of cardiovascular disease and diabetes mellitus
by: M. V. Stroeva, et al.
Published: (2010-04-01)

WHAT CAN WE EXPECT USING ACE INHIBITOR RAMIPRIL IN PERSONS WITH HIGH CARDIOVASCULAR RISK AND EARLY DISORDERS OF CARBOHYDRATE METABOLISM? LESSONS OF DREAM TRIAL
by: M. N. Mamedov, et al.
Published: (2016-01-01)

EARLY DISTURBANCES OF CARBOHYDRATE METABOLISM — A TARGET FOR PRIMARY CARDIOVASCULAR PREVENTION
by: M. N. Kovrigina, et al.
Published: (2013-04-01)

Evidence-based principles of early diagnostics of carbohydrate metabolism disturbances in the internal disease practice
by: E. A. Poddubskaya, et al.
Published: (2012-10-01)

Comparative effectiveness of fixed combinations of various ramipril and hydrochlorothiazide doses
by: I. E. Chazova, et al.
Published: (2010-08-01)

The Possibilities of Single-Pill Combinations of Antihypertensive Drugs in Cerebroprotection: Focus on the Combination of Amlodipine with Ramipril
by: A. I. Kochetkov, et al.
Published: (2020-07-01)

Noliprel and endothelial dysfunction correction in metabolic syndrome patients
by: V. V. Trusov, et al.
Published: (2005-12-01)

ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK
by: M. N. Kovrigina, et al.
Published: (2015-12-01)

Integrating modern antihypertensive therapy and patient education in real-world clinical practice: maximal reduction of total cardiovascular risk. NOCTURNE-2 Study
by: R. G. Oganov, et al.
Published: (2009-12-01)

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
by: A. O. Konradi, et al.
Published: (2020-04-01)

Combined antihypertensive medications
by: L. L. Kirichenko, et al.
Published: (2007-12-01)

Fixed dose combination of perindopril with indapamide in primary prevention of cerebrovascular complications among patients with metabolic syndrome and arterial hypertension
by: V. B. Mychka, et al.
Published: (2006-02-01)

EXPERIENCE OF RAMIPRIL (HARTIL) USAGE IN PATIENTS WITH HIGH CARDIOVASCULAR RISK (THE OPTIMIST STUDY)
by: I. A. Velizhanina, et al.
Published: (2016-01-01)

Combined lipid-lowering and antihypertensive therapy effects on hemostasis in metabolic sydrome patients
by: L. A. Ratnikova, et al.
Published: (2006-04-01)

Cardiovascular disease prevalence in climacteric women with carbohydrate metabolism disorders
by: N. V. N.V. Izmozherova, et al.
Published: (2008-02-01)

A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist
by: S. R. Gilyarevskiy, et al.
Published: (2019-05-01)

Effectiveness and safety of a fixed, low-dose perindopril/ indapamide combination in patients with arterial hypertension: real-world clinical practice data (STRATEGYA, a multi-center, open, prospective study)
by: T. V. Matrynyuk, et al.
Published: (1970-01-01)

Antihypertensive therapy and diabetes mellitus incidence: is it possible to reduce the risk?
by: M. G. Glezer
Published: (2008-12-01)

Choice Between Free Combination of Antihypertensive Agents and Fixed Dosed Combinations in the Treatment of Arterial Hypertension
by: O. S. Levchenkova, et al.
Published: (2024-10-01)

Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
by: L. I. Abasova, et al.
Published: (2011-08-01)

COMBINED ANTIHYPERTENSIVE THERAPY IN REAL CLINICAL PRACTICE. FOCUS ON FIXED COMBINATIONS OF ANTIHYPERTENSIVE DRUGS (According to the Data of Outpatient Registries RECVASA and PROFILE)
by: S. Yu. Martsevich, et al.
Published: (2017-07-01)

Antihypertensive and Target-Organ Protective Properties of Telmisartan and Hydrochlorothiazide Single-Pill Combination
by: O. D. Ostroumova, et al.
Published: (2019-09-01)

USE OF FIXED COMBINATIONS OF RAMIPRIL AND HYDROCHLOROTHIAZIDE IN PATIENTS WITH ARTERIAL HYPERTENSION AND HIGH OR VERY HIGH CARDIOVASCULAR RISK (OPTIMIST 2 STUDY): RESULTS OF THE NONCOMPARATIVE STUDY
by: I. A. Velizhanina, et al.
Published: (2016-01-01)

STUDY OF PATIENTS ADHERENCE TO TREATMENT IN METABOLIC SYNDROME, WITH THE NOVEL COMBINATION ANTIHYPERTENSION COMPOUND OF RAMIPRIL AND AMLODIPINE BY THE DATA OF OBSERVATIONAL STUDY GRANAT-1
by: S. Yu. Martsevich, et al.
Published: (2017-02-01)

Pharmacotherapy efficacy assessment in arterial hypertension with metabolic disturbances
by: A. A. Demin, et al.
Published: (2005-06-01)

PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE
by: E. I. Tarlovskaya, et al.
Published: (2015-09-01)

COMBINATION ANTIHYPERTENSION THERAPY: TRIPLE FIXED COMBINATION OF ANTIHYPERTENSIVE DRUGS
by: O. D. Ostroumova, et al.
Published: (2017-02-01)

An overview of fixed-dose combinations of antihypertensive drugs in South Africa
by: Natalie Schellack, et al.
Published: (2014-07-01)

Prevalence of hyperuricemia in professional athletes and its role in the genesis of various pathological conditions and metabolic disturbances
by: M. S. Eliseev, et al.
Published: (2018-09-01)

Ramipril and amlodipine therapy effects on endothelial vasodilatation, metabolic profile, and arterial hypertension course in women with postmenopausal metabolic syndrome
by: A. R. Ishmanova, et al.
Published: (2010-02-01)

ANALYSIS OF THE PRACTICE OF COMBINATIONAL ANTIHYPERTENSION THERAPY BY THE DATA FROM TWO OUTPATIENT REGISTRIES
by: S. Yu. Martsevich, et al.
Published: (2017-10-01)

THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

SPECIFICS OF ANTIHYPERTENSION THERAPY IN HYPERTENSIVES OF VARIOUS CARDIOVASCULAR RISK (BY THE REGISTRY OF CHRONIC NON-COMMUNICABLE DISEASES IN TYUMENSKAYA OBLAST)
by: A. Yu. Efanov, et al.
Published: (2018-06-01)

Results of the multi-centre study NOCTURN-2 in patients with arterial hypertension, uncontrolled by previous pharmaceutical therapy
by: R. G. Oganov, et al.
Published: (2010-02-01)

Adherence to antihypertensive therapy is a way to improve cardiovascular prognosis
by: H. D. Kosmacheva, et al.
Published: (2025-06-01)

SEARCH FOR UNIVERSAL COMBINED ANTIHYPERTENSIVE THERAPY WITHIN LIMITED DATA ON THE COMPARATIVE EFFICACY OF ANTIHYPERTENSIVE AGENTS
by: S. R. Gilyarevskiy
Published: (2015-09-01)

INDIVIDUAL, ABSOLUTE AND RELATIVE CARDIOVASCULAR RISK IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION AND ITS DYNAMICS UNDER ANTIHYPERTENSIVE TREATMENT
by: B. A. Hapayev, et al.
Published: (2001-06-01)

CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA)
by: M. M. Loukianov, et al.
Published: (2016-03-01)

Cardiovascular-kidney-metabolic syndrome — a new concept of the association of risk factors and metabolic disorders within the cardiovascular and renal continuum. View on the issue
by: G. G. Arabidze, et al.
Published: (2024-06-01)